Caspase-12 attenuated parasite clearance in blood-stage malaria and impacted susceptibility to cerebral malaria by limiting immune control of parasite replication and reducing cerebral hyperinflammation in a cerebral malaria model. Here, CASP12 is linked to cerebral malaria.